8-Hydroxy-2′-deoxyguanosine is a prognostic mediator for cardiac event
- 25 January 2011
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 41 (7) , 759-766
Abstract
Eur J Clin Invest 2011; 41 (7): 759–766 Abstract Background DNA in the nucleus is one of the major targets of reactive oxygen species (ROS), and oxidative DNA damage has been implicated in the pathogenesis of chronic heart failure. 8‐Hydroxy‐2′‐deoxyguanosine (8‐OHdG) is produced from deoxyguanosine in DNA by ROS. The purpose of this present study was to examine the clinical significance of serum 8‐OHdG levels in patients with heart failure. Methods We measured serum 8‐OHdG levels in 230 patients with chronic heart failure and 42 control subjects without heart failure by sandwich enzyme‐linked immunosorbent assay. Patients were prospectively followed during a median follow‐up period of 472 days with the end points of cardiac death or progressive heart failure requiring re‐hospitalization. Results Serum 8‐OHdG concentrations were higher in patients with heart failure than in control subjects (P < 0·001) and increased with advancing New York Heart Association (NYHA) functional class (P < 0·001). Normal upper limit of 8‐OHdG level was determined as mean ± 2SD value from 42 control subjects (0·40 ng mL−1). Abnormally high serum 8‐OHdG levels (> 0·40 ng mL−1) were observed in 21·2%, 43·1%, 42·6% and 69·4% through NYHA I to IV (P < 0·001). A total of 66 cardiac events occurred during a follow‐up period, and Kaplan–Meier survival curves demonstrated that cardiac event rate was markedly higher in patients with high 8‐OHdG levels than in those with normal 8‐OHdG levels (62·4% vs. 29·6%, P = 0·0007). Conclusions Serum 8‐OHdG levels provide important prognostic information for the risk stratification of patients with heart failure.Keywords
This publication has 40 references indexed in Scilit:
- Toll-like Receptor 2 Is Essential for the Sensing of Oxidants during InflammationAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Mitochondrial oxidative stress and dysfunction in myocardial remodellingCardiovascular Research, 2008
- Effects of MEK5/ERK5 Association on Small Ubiquitin-Related Modification of ERK5: Implications for Diabetic Ventricular Dysfunction After Myocardial InfarctionCirculation Research, 2008
- Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarctionFree Radical Biology and Medicine, 2007
- Role of Oxidative Stress in Cardiac Hypertrophy and RemodelingHypertension, 2007
- Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazoneAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Plasma Myeloperoxidase Levels in Patients With Chronic Heart FailureThe American Journal of Cardiology, 2006
- Modulation of Doxorubicin-Induced Cardiac Dysfunction in Toll-Like Receptor-2–Knockout MiceCirculation, 2004
- Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart FailureCirculation, 2002
- DNA Damage in Deoxynucleosides and Oligonucleotides Treated with PeroxynitriteChemical Research in Toxicology, 1999